NYSE:CTVAChemicals
What Corteva (CTVA)'s Upbeat 2025 Outlook and Buybacks Mean for Shareholders
Corteva reported second quarter 2025 earnings, showing higher net income and sales compared to the prior year, and revised its full-year 2025 guidance upward, projecting net sales of US$17.6 billion to US$17.8 billion and operating earnings per share of US$3.00 to US$3.20.
Alongside strong financial results, Corteva completed share repurchases totaling over 35.7 million shares since late 2022, while also addressing legacy environmental claims through a comprehensive legal settlement in New...